van den Berg A P, van Son W J, Janssen R A, Brons N H, Heyn A A, Scholten-Sampson A, Postma S, van der Giessen M, Tegzess A M, de Leij L H
Department of Clinical Immunology, University Hospital, Groningen, Netherlands.
J Infect Dis. 1992 Dec;166(6):1228-35. doi: 10.1093/infdis/166.6.1228.
The number of CD8bright and CD56+ lymphocytes in the peripheral blood and their activation status were monitored by flow cytometry in 23 renal transplant recipients with cytomegalovirus (CMV) infection and were correlated with the virus load (as determined by CMV antigenemia) and clinical symptoms. Recovery from CMV infection coincided with expansion of the CD8bright and CD56+ subsets and with increased expression of the activation marker HLA-DR. Primary infection was associated with activation of both subsets, whereas during secondary infection, mainly CD8bright cells responded. Progressive CMV disease (requiring antiviral treatment) and relapse occurred in association with low numbers of activated CD8bright and CD56+ cells. Lymphocyte activation and antibody responses against CMV often occurred simultaneously, but different kinetics of these responses in some patients indicated that cellular responses are necessary to control viral replication, whereas humoral responses alone may be insufficient. Monitoring of lymphocyte activation may provide clinically useful information during CMV infection.
通过流式细胞术监测了23例巨细胞病毒(CMV)感染的肾移植受者外周血中CD8bright和CD56+淋巴细胞的数量及其活化状态,并将其与病毒载量(通过CMV抗原血症测定)和临床症状相关联。CMV感染的恢复与CD8bright和CD56+亚群的扩增以及活化标志物HLA-DR表达的增加相一致。原发性感染与两个亚群的活化相关,而在继发性感染期间,主要是CD8bright细胞做出反应。进行性CMV疾病(需要抗病毒治疗)和复发与活化的CD8bright和CD56+细胞数量少有关。淋巴细胞活化和针对CMV的抗体反应经常同时发生,但某些患者中这些反应的不同动力学表明,细胞反应对于控制病毒复制是必要的,而仅体液反应可能是不够的。监测淋巴细胞活化可能在CMV感染期间提供临床有用信息。